Rivaroxaban CYP3A4 Food Interaction Magnitude

Calculate rivaroxaban bioavailability change from food intake timing and CYP3A4/P-gp interacting drugs.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Calculate rivaroxaban bioavailability change from food intake timing and CYP3A4/P-gp interacting drugs

Each component has a specific meaning:

  • Food intake timing — The food intake timing recorded for the scenario being assessed.
  • CYP3A4/P-gp interacting drugs — The cyp3a4/p-gp interacting drugs recorded for the scenario being assessed.

Note: Interpret the rivaroxaban cyp3a4 result against the thresholds and context described above.

How to Use

Enter the food intake timing, CYP3A4/P-gp interacting drugs for the scenario you are assessing. Calculate rivaroxaban bioavailability change from food intake timing and CYP3A4/P-gp interacting drugs. Use the rivaroxaban cyp3a4 result to inform your calculation.

Related Calculators

Apixaban CYP3A4

Medical Ultra-depth

Dabigatran P-gp

Medical Ultra-depth

Frequently Asked Questions